Skip to main content
. 2023 Jan 23;19(1):e1010753. doi: 10.1371/journal.ppat.1010753

Table 1. Primers used in this study.

Primer Forward primer Reverse primer
LANA ACTGAACACACGGACAACGG CAGGTTCTCCCATCGACGA
K8.1 AAAGCGTCCAGGCCACCACAGA GGCAGAAAATGGCACACGGTTAC
ALU human GGTGAAACCCCGTCTCTACT GGTTCAAGCGATTCTCCTGC
genomic actin AGAAAATCTGGCACCACACC AACGGCAGAAGAGAGAACCA
CD31 AACAGTGTTGACATGAAGAGCC TGTAAAACAGCACGTCATCCTT
VEGFC GCCAATCACACTTCCTGCCGA AGGTCTTGTTCGCTGCCTGAC
LYVE1 CTGCATGACACCTGGATGGA AAGGGCTGGAAACAAGGACA
Podoplanin CGAAGATGATGTGGTGACTC CGATGCGAATGCCTGTTAC
CD44 CCCATCCCAGACGAAGACAG ACCATGAAAACCAATCCCAGG
CD90 THY1 TCGCTCTCCTGCTAACAGTCT CTCGTACTGGATGGGTGAACT
aSMA GACCCTGAAGTACCCGATAGAAC GGGCAACACGAAGCTCATTG
ZEB1 GATGATGAATGCGAGTCAGATGC ACAGCAGTGTCTTGTTGTTGTAG
SNAI1 GCATTTCTTCACTCCGAAGC TGAATTCCATGCTCTTGCAG
ETS1 GAGCTTTTCCCCTCCCCGGAT TGCCGGGGGTCTTTTGGGAT
ETS2 AGGAGTTTCAGATGTTCCCC GTCCCAGAATTGTTGGTGAG
MMP1 AGTCCGGTTTTTCAAAGGGAA CCTTGGGGTATCCGTGTAGC
CXCR4 GCCAACGTCAGTGAGGCAGA GCCAACCATGATGTGCTGAAAC
IL6 GAACCTTCCAAAGATGGCTGA CAAACTCCAAAAGACCAGTGATG
TGFB3 TGAGCACATTGCCAAACAGC ACTCAGTGGCAAAGCTAGGG
SOX18 CTTCATGGTGTGGGCAAAG GCGTTCAGCTCCTTCCAC
actin TCACCCACACTGTGCCATCTACGA CAGCGGAACCGCTCATTGCCAATGG
GAPDH AAGGTGAAGGTCGGAGTCAAC TGGAAGATGGTGATGGGATTTC
Viperin GTGAGCAATGGAAGCCTGATC GCTGTCACAGGAGATAGCGAGAA
IFI6 CCTCGCTGATGAGCTGGTCT CTATCGAGATACTTGTGGGTGGC
IL1R1 AGAGGAAAACAAACCCACAAGG CTGGCCGGTGACATTACAGA
MyD88 GCACATGGGCACATACAGAC GACATGGTTAGGCTCCCTCA